Search research articles
Contact Us
Filters
Showing results (651-660 of 666) with videos related to
Page
of 67
Sort By:
Seminars in Arthritis and Rheumatism
|
June 3, 2019
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
Massimo Radin, Savino Sciascia, Doruk Erkan, et al.
Leukemia
|
June 11, 2016
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
H Parker, M J J Rose-Zerilli, M Larrayoz, et al.
The Journal of Clinical Investigation
|
June 9, 2026
Aberrant STAT signaling and T cell dysregulation define a targetable pediatric sepsis endotype
Robert B Lindell, Samir U Sayed, Jose S Campos Duran, et al.
European Heart Journal
|
February 17, 2021
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance
Tushar Kotecha, Daniel S Knight, Yousuf Razvi, et al.
Nature Reviews. Cardiology
|
March 11, 2026
Antiphospholipid antibodies and cardiovascular thrombosis
Sina Rashedi, Hannah Leyva, Saman A Siddiqui, et al.
Arthritis Care & Research
|
February 3, 2025
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository
Yasaman Ahmadzadeh, Larry S Magder, Danieli Castro Oliveira de Andrade, et al.
Biorxiv : the Preprint Server for Biology
|
December 23, 2024
Altered Purinergic Signaling and CD8+ T Cell Dysregulation in STAT3 GOF Syndrome
Jose S Campos Duran, Samir Sayed, Megan C Dalalo, et al.
Advances in Rheumatology (London, England)
|
April 17, 2026
Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registry
Elena Gkrouzman, Alicia Matijasevich, Carolina Bonilla Richero, et al.
JCI Insight
|
April 1, 2025
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection
Pei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.
Cell Death and Differentiation
|
May 25, 2021
Patients with COVID-19: in the dark-NETs of neutrophils
Maximilian Ackermann, Hans-Joachim Anders, Rostyslav Bilyy, et al.
Page
of 67
Search research articles
Search
Showing results (651-660 of 666) with videos related to
Sort By:
Page
of 67
Seminars in Arthritis and Rheumatism
|
June 3, 2019
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
Massimo Radin, Savino Sciascia, Doruk Erkan, et al.
Leukemia
|
June 11, 2016
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
H Parker, M J J Rose-Zerilli, M Larrayoz, et al.
The Journal of Clinical Investigation
|
June 9, 2026
Aberrant STAT signaling and T cell dysregulation define a targetable pediatric sepsis endotype
Robert B Lindell, Samir U Sayed, Jose S Campos Duran, et al.
European Heart Journal
|
February 17, 2021
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance
Tushar Kotecha, Daniel S Knight, Yousuf Razvi, et al.
Nature Reviews. Cardiology
|
March 11, 2026
Antiphospholipid antibodies and cardiovascular thrombosis
Sina Rashedi, Hannah Leyva, Saman A Siddiqui, et al.
Arthritis Care & Research
|
February 3, 2025
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository
Yasaman Ahmadzadeh, Larry S Magder, Danieli Castro Oliveira de Andrade, et al.
Biorxiv : the Preprint Server for Biology
|
December 23, 2024
Altered Purinergic Signaling and CD8+ T Cell Dysregulation in STAT3 GOF Syndrome
Jose S Campos Duran, Samir Sayed, Megan C Dalalo, et al.
Advances in Rheumatology (London, England)
|
April 17, 2026
Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registry
Elena Gkrouzman, Alicia Matijasevich, Carolina Bonilla Richero, et al.
JCI Insight
|
April 1, 2025
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection
Pei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.
Cell Death and Differentiation
|
May 25, 2021
Patients with COVID-19: in the dark-NETs of neutrophils
Maximilian Ackermann, Hans-Joachim Anders, Rostyslav Bilyy, et al.
Page
of 67